
In response to demands to reduce costs, Eli Lilly lowers insulin prices by up to 70%.
Eli Lilly announced on Wednesday that it would expand a program that restricts patient expenses at $35 per month and reduce the cost of its most frequently prescribed insulin treatments by 70%. Although most individuals with diabetes can obtain insulin through the present healthcare system, not everyone can afford it, and this needs to change,…